Yuhan Corporation
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Yuhan Corporation
RECRUITINGPhase 1 / Phase 2NCT06975410
Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
This is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Adults aged 18 and over with advanced cancer with Epidermal...
Sponsor: Yuhan CorporationEnrolling: 804 locations
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
RECRUITINGPhase 1NCT06517914
A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants
This is a randomized, double-blind, first-in-human study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of YH35995
Sponsor: Yuhan CorporationEnrolling: 861 location
Healthy Participants